287 related articles for article (PubMed ID: 22581388)
1. Nifedipine versus labetalol in the treatment of hypertensive disorders of pregnancy.
Giannubilo SR; Bezzeccheri V; Cecchi S; Landi B; Battistoni GI; Vitali P; Cecchi L; Tranquilli AL
Arch Gynecol Obstet; 2012 Sep; 286(3):637-42. PubMed ID: 22581388
[TBL] [Abstract][Full Text] [Related]
2. Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa.
Molvi SN; Mir S; Rana VS; Jabeen F; Malik AR
Arch Gynecol Obstet; 2012 Jun; 285(6):1553-62. PubMed ID: 22249781
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy.
Vermillion ST; Scardo JA; Newman RB; Chauhan SP
Am J Obstet Gynecol; 1999 Oct; 181(4):858-61. PubMed ID: 10521742
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies.
Scardo JA; Vermillion ST; Newman RB; Chauhan SP; Hogg BB
Am J Obstet Gynecol; 1999 Oct; 181(4):862-6. PubMed ID: 10521743
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive drugs in pregnancy.
Naden RP; Redman CW
Clin Perinatol; 1985 Oct; 12(3):521-38. PubMed ID: 2865023
[TBL] [Abstract][Full Text] [Related]
6. Use of antihypertensive drugs during pregnancy and lactation.
Ghanem FA; Movahed A
Cardiovasc Ther; 2008; 26(1):38-49. PubMed ID: 18466419
[TBL] [Abstract][Full Text] [Related]
7. The "weight" of fetal growth restriction in 437 hypertensive pregnancies.
Tranquilli AL; Giannubilo SR
Arch Gynecol Obstet; 2004 Dec; 270(4):214-6. PubMed ID: 12942263
[TBL] [Abstract][Full Text] [Related]
8. The effect of labetalol and nifedipine MR on blood pressure in women with chronic hypertension in pregnancy.
Shawkat E; Mistry H; Chmiel C; Webster L; Chappell L; Johnstone ED; Myers JE
Pregnancy Hypertens; 2018 Jan; 11():92-98. PubMed ID: 29523282
[TBL] [Abstract][Full Text] [Related]
9. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial.
Raheem IA; Saaid R; Omar SZ; Tan PC
BJOG; 2012 Jan; 119(1):78-85. PubMed ID: 21985500
[TBL] [Abstract][Full Text] [Related]
10. Trends in using beta-blockers and methyldopa for hypertensive disorders during pregnancy in a Canadian population.
Xie RH; Guo Y; Krewski D; Mattison D; Nerenberg K; Walker MC; Wen SW
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):281-5. PubMed ID: 24139131
[TBL] [Abstract][Full Text] [Related]
11. Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center.
Yücesoy G; Ozkan S; Bodur H; Tan T; Calişkan E; Vural B; Corakçi A
Arch Gynecol Obstet; 2005 Nov; 273(1):43-9. PubMed ID: 15834580
[TBL] [Abstract][Full Text] [Related]
12. [Current perspective of treating hypertension in pregnancy].
Koucký M
Vnitr Lek; 2011 Sep; 57(9):728-31. PubMed ID: 21957765
[TBL] [Abstract][Full Text] [Related]
13. Hypertension in pregnancy.
Podymow T; August P
Adv Chronic Kidney Dis; 2007 Apr; 14(2):178-90. PubMed ID: 17395120
[TBL] [Abstract][Full Text] [Related]
14. Evaluation and Management of Hypertensive Disorders of Pregnancy.
Bajpai D; Popa C; Verma P; Dumanski S; Shah S
Kidney360; 2023 Oct; 4(10):1512-1525. PubMed ID: 37526641
[TBL] [Abstract][Full Text] [Related]
15. Intravenous labetalol versus oral nifedipine for acute hypertension in pregnancy: effects on cerebral perfusion pressure.
Tolcher MC; Fox KA; Sangi-Haghpeykar H; Clark SL; Belfort MA
Am J Obstet Gynecol; 2020 Sep; 223(3):441.e1-441.e8. PubMed ID: 32544404
[TBL] [Abstract][Full Text] [Related]
16. Hypertensive emergencies in pregnancy.
Vadhera RB; Simon M
Clin Obstet Gynecol; 2014 Dec; 57(4):797-805. PubMed ID: 25314092
[TBL] [Abstract][Full Text] [Related]
17. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
Easterling T; Mundle S; Bracken H; Parvekar S; Mool S; Magee LA; von Dadelszen P; Shochet T; Winikoff B
Lancet; 2019 Sep; 394(10203):1011-1021. PubMed ID: 31378394
[TBL] [Abstract][Full Text] [Related]
18. Neonatal side effects of maternal labetalol treatment in severe preeclampsia.
Heida KY; Zeeman GG; Van Veen TR; Hulzebos CV
Early Hum Dev; 2012 Jul; 88(7):503-7. PubMed ID: 22525036
[TBL] [Abstract][Full Text] [Related]
19. Severe maternal morbidity in a large cohort of women with acute severe intrapartum hypertension.
Kilpatrick SJ; Abreo A; Greene N; Melsop K; Peterson N; Shields LE; Main EK
Am J Obstet Gynecol; 2016 Jul; 215(1):91.e1-7. PubMed ID: 26829504
[TBL] [Abstract][Full Text] [Related]
20. Sympathetic (alpha-beta) or calcium channel blockade for hypertensive myocardial infarction? A haemodynamic comparison of labetalol and nifedipine.
Verma SP; Silke B; Hussain M; Nelson GI; Wilson JA; Reynolds GW; Richmond A; Taylor SH
J Hypertens; 1988 Nov; 6(11):897-904. PubMed ID: 2906956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
